Mereo BioPharma Group plc Holding(s) in Company (3192P)
2020年6月9日 - 1:56AM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMMPH TIDMSDR
RNS Number : 3192P
Mereo BioPharma Group plc
08 June 2020
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Mereo Biopharma Group plc
underlying issuer of existing shares
to which voting rights are attached
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) : X
1. Type 1 & Type 3 disclosure as per the Transparency Directive
II regulation
2. This disclosure is being made due to a change in denominator
----
3. Details of person subject to the notification obligation (iv)
Name Schroders plc
City and country of registered office London, UK
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 05.06.2020
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 08.06.2020
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached Below 5% N/A Below 5% 213,652,487
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 8.009% N/A 8.009%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of (Art 9 of Directive (Art 10
2004/109/EC) Directive 2004/109/EC) 2004/109/EC) of Directive
(DTR5.1) (DTR5.2.1) (DTR5.1) 2004/109/EC)
(DTR5.2.1)
--------------------------------
GB00BZ4G2K23 Below 5% Below 5%
------------------------ -------------------------------- ------------------------ -------------------
SUBTOTAL 8. A Below 5% Below 5%
---------------------------------------------------------- ---------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (x) Conversion Period rights that may rights
(xi) be acquired if
the instrument
is
exercised/converted.
------------- ---------------------------------- --------------------------------- -------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical Number of % of voting
instrument date (x) Conversion or cash voting rights rights
Period (xi) settlement
(xii)
--------------- ---------------------- ------------------------ -------------------
SUBTOTAL
8.B.2
------------------------ -------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of
if it equals or through financial both if it
is higher than instruments if equals or
the notifiable it equals or is is higher
threshold higher than the than the
notifiable threshold notifiable
threshold
------------------------------------- ------------------------------- ----------------------
Schroders plc
------------------------------------- ------------------------------- ----------------------
Schroder Administration
Limited
------------------------------------- ------------------------------- ----------------------
Schroder International
Holdings Limited
------------------------------------- ------------------------------- ----------------------
Schroder Investment
Management
Limited
------------------------------------- ------------------------------- ----------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-------------------------------------------------------
The number and % of voting rights held
-------------------------------------------------------
The date until which the voting rights
will be held
-------------------------------------------------------
11. Additional information (xvi)
Place of completion London
Date of completion 08.06.2020
-----------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLFPMFTMTAMBTM
(END) Dow Jones Newswires
June 08, 2020 12:56 ET (16:56 GMT)
Mereo Biopharma (LSE:MPH)
過去 株価チャート
から 12 2024 まで 1 2025
Mereo Biopharma (LSE:MPH)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Mereo Biopharma Group Plc (ロンドン証券取引所): 0 recent articles
その他のMereo Biopharma Group Plcニュース記事